HealthValue Group

  • About Us
  • Services
    • Business Valuation
    • Capital Equipment Valuation
    • Litigation Support Services
    • Fair Market Value (FMV) Opinions
  • News & Insights
    • Subscribe
    • FMV QuickRead
    • Trending Stories
    • Sector Snapshot
    • Healthcare Attorney Spotlight
    • Publications
  • Testimonials
  • Leadership
  • Events
  • Careers
  • Contact Us

Is there a Commercially Reasonable (CR) Risk with Cost-Plus Management Fees?

August 31, 2022 By Chris David

Many MSA fee structures are based on a cost-plus fee structure.  And often times the MSO cannot accurately forecast the expenses of providing management services. So one question is whether the actual expenses incurred by the MSO are reasonable and sensible.  It’s my understanding that the Stark Law guidance on CR relates to whether an entire arrangement is “reasonable” and/or “furthers a legitimate business purpose.”  Even though the Stark Law doesn’t explicitly address the reasonableness of individual expenses within an arrangement, does it cover the reasonableness of certain expenses?  This issue also exists with COVID specimen collection arrangements and whether certain expenses are really necessary and reasonable.

The question to the FMV compliance community is do you believe MSAs and other types of arrangements need to be smell-tested for reasonableness of expense?

Filed Under: FMV QuickRead

5600 Greenwood Plaza Blvd., STE 300, Greenwood Village, CO 80111 • (303) 918-3607

Copyright © 2023 HealthValue Group is an appraisal and consulting firm providing business valuations and fair market value opinions and is not a certified public accounting firm or a law firm. No information on this site should be considered a formal appraisal or opinion for a specific asset or service. No information on this site should be construed as a legal opinion or advise. All Rights Reserved.